The Duke Clinical & Translational Science Institute (CTSI) is the academic home of the National Institutes of Health Clinical and Translational Science Award (CTSA) at Duke University and North Carolina Central University (NCCU). This funding mechanism supports Pilot projects focused on advancing Translational Science.
As defined by the National Center for Advancing Translational Sciences (NCATS), Translational Science is the field of investigation focused on understanding the scientific and operational principles underlying each step of the translational process. Whereas translational research focuses on the specific case of a target or disease, translational science focuses on the general case that can be applied to research on any target or disease. See specific examples of Translational Research (TR) vs Translational Science (TS) projects.
Like any other science, translational science seeks to elucidate general operative principles to transform translation from an empirical, phenomenological process into a predictive science. The application of scientific and operational innovation and strategies to improve the efficiency and effectiveness of all research is at the heart of developing, demonstrating, and disseminating the science of translation.
Only projects that develop methodologies and/or generalizable solutions that address common challenges and roadblocks across the translational spectrum will be funded. The Duke-NCCU CTSA has a strong focus on healthy equity; projects that seek to elucidate mechanisms and solutions to overcome translational roadblocks to achieving health equity are strongly encouraged. Proposals should demonstrate community engagement to facilitate the exchange of knowledge with those who will implement findings.
Deadlines:
-
Mandatory Letter of Intent Deadline: February 28, 2023
-
Full Application Deadline: April 3, 2023